Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High versus low dose intravenous dexamethasone after nephrectomy
2017-000505-20Phase 4Terminated
- Sponsor
- Eske Kvanner Aasvang
- Start
- Feb 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone in postoperative pain, postoperative nausea and vomiting (PONV) and complications of surgical procedures (2 arms), sponsored by Eske Kvanner Aasvang. Primary endpoint: Complications in PACU according to discharge criteria. Started Feb 2017; status: terminated.
02
Drugs
dexamethasone
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)complications of surgical procedures
Beyond the preview
Go deeper on 2017-000505-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000505-20.